SC: Confirmation of an Auction Sale Does Not Bar Judicial Scrutiny of Reserve Price Valuation  ||  Supreme Court Sets Aside Conviction of Four Men in a 1998 Gang Rape Case  ||  Supreme Court: Privy Purse Privileges of Princely Rulers are Not Enforceable Legal Rights  ||  Delhi HC: Repeated Court Summons May Distress and Re-Traumatize Child Sexual Assault Victims  ||  Jammu and Kashmir High Court: Labeling Someone as a Terrorist Associate Amounts to Defamation  ||  Delhi HC: Setting Aside or Altering a Judge’s Order by a Higher Court Doesn’t Affect Their Integrity  ||  Delhi High Court: Accused Cannot be Faulted For Smart Replies; Interrogator Must be Sharper  ||  Supreme Court: Belated Jurisdictional Challenge Impermissible After Participation in Arbitration  ||  Supreme Court: Failure to Prove Specific Overt Acts of Each Unlawful Assembly Member Not Fatal  ||  Supreme Court: Parental Salary Alone Cannot Determine OBC Creamy Layer Status    

Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin” - (14 Dec 2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporation claiming monopoly rights on a new diabetes drug, teneligliptin, on grounds that it was "obvious, and lacking inventive step".

Tags : KOLKATA PATENT OFFICE   PATENT   DIABETES DRUG TENELIGLIPTIN  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved